Abstract:Objective To evaluate the risk factors associated with in-hospital death in patients co-infected with human immunodeficiency virus and Mycobacterium tuberculosis (HIV-TB). Methods A retrospective case-control study was performed in patients admitted to Shanghai Public Health Clinical Center from November 2004 to May 2009. Fifty-three HIV-TB patients who died during hospitalization were matched with 79 HIV-TB co-infected patients who survived during hospitalization.Clinical, demographic, and radiological characteristics of the two groups were compared by the retrospective case-control study method. Multivariate Logistic stepwise regression analysis was performed to explore the risk factors contributing to death in HIV-TB co-infected patients. Results Among the 459 co-infected patients, 53 (11.5%) cases died during hospitalization and 25 cases died during the first week in hospital. Sixty-four point two percent dead patients (34/53) died from tuberculosis. Several factors were associated with worse prognosis in the death group compared to the survival group, which included body weight≤50 kg (χ2 = 7.50), positive for acid-fast bacilli in sputum smear or culture exam (χ2= 4. 04, 14. 27), drug-resistant/multi-drug resistant Mycobacterium tuberculosis infection (χ2 =9.00,6.39), extra-pulmonary tuberculosis infection (χ2 =6.99), retreated tuberculosis (χ2 = 5. 92), non-standardized anti-tuberculosis treatment (χ2 = 12. 07), extensive pulmonary TB infection (lesions ≥50% of lung fields, χ2 = 20. 21), co-infection with fungi (χ2 =3.46), respiratory failure (χ2 = 4.27), non-pulmonary organ impairment (χ2 = 3.46), HIV infection longer than 5 years (χ2 = 7. 19), non-standardized highly active antiretroviral therary treatment (χ2 =5.16) and CD4+ T lymphocyte count ≤ 200 × 106/L (χ2= 12.99) (all P＜0. 05). Multivariate Logistic regression analysis showed that non-standardized anti-TB treatment, extensive pulmonary TB infection, multi-drug resistant TB infection and CD4+ T lymphocyte count ≤ 200 × 106/L were the major risk factors related to in-hospital mortality. Conclusions Non-standardized anti-TB treatment,extensive pulmonary TB infection, multi-drug resistant TB infection and CD4+ T lymphocyte count ≤200 × 106/L are the major risk factors related to in-hospital mortality in the patients co-infected with TB and HIV.

Features of Death from Human Immunodeficiency Virus Infection Complicated with Tuberculosis

Factors related to in-hospital deaths in patients co-infected with human immunodeficiency virus and tuberculosis

[Clinical features of 23 cases of AIDS complicated by tuberculosis].

A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipality

[The clinical and morphological features of the course of tuberculosis in HIV infection]

Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in southern China: a cohort study

Clinical epidemiology of 359 cases of acquired immunodeficiency syndrome and pulmonary tuberculosis co-infection

Diagnosis and treatment for mycobacterium tuberculosis in human immunodeficiency virus-infected patients

Clinical Symptoms and Immune Injury Reflected by Low CD4/CD8 Ratio Should Increase the Suspicion of HIV Coinfection with Tuberculosis

Clinical Characteristics and Prognosis of Human Immunodeficiency Virus Infected Patients with Tuberculous Meningitis

Preliminary Research: Correlation between the Appearances of CT in HIV/AIDS Patients Complicated with Tuberrulosis and Pulmonary Function

Analysis on Influence Factors of HIV/TB Double Infection Death Cases in Mang City

Studies on the diagnostic techniques in HIV/AIDS complicated with mycobacterium tuberculosis infection and resistant phenotype

Population differences in death rates in HIV-positive patients with tuberculosis.

The causes of death for 89 HIV/AIDS patients

The Role of CD4+CD8+ T Cells in HIV Infection With Tuberculosis

Study on Mycobacterium tuberculosis-specific cellular immunity in individuals co-infected with Mycobacterium tuberculosis and human immunodeficiency virus

HIV co-infection increases the risk of post-tuberculosis mortality among persons who initiated treatment for drug-resistant tuberculosis

Clinical and Epidemiological Characteristics of COVID-19 in Persons Living with HIV Complicated by Tuberculosis

The relationship between CD4+ T lymphocyte count and Mycobacterium tuberculosis coinfection in human immunodeficiency virus-infected patients